Use of β-blockers and aspirin after myocardial infarction by patient renal function in the department of defense health care system

American Journal of Kidney Diseases

Volumn 47, Issue 4, 2006, Pages 593-603

  Abbott, Kevin C ^a   Bohen, Erin M ^b   Yuan, Christina M ^b   Yeo, Frederick E ^b   Sawyers, Eric S ^b   Perkins, Robert M ^b   Lentine, Krista L ^b   Oliver, David K ^b   Galey, Joanie ^b   Sebastianelli, Mary E ^b   Scally, John P ^b   Taylor, Allen J ^b   Boal, Thomas R ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

blockers; Aspirin; Coronary care unit; Creatinine; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; CREATININE BLOOD LEVEL; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE SYSTEM; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY;

ADRENERGIC BETA-ANTAGONISTS; AGED; ASPIRIN; CREATININE; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 33645224653     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.01.006     Document Type: Article

References (21)

1. D.E. Weiner, H. Tighiouart, M.G. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality A pooled analysis of community-based studies J Am Soc Nephrol 15 2004 1307 1315
2. H.U. Meier-Kriesche, R. Baliga, B. Kaplan Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation Transplantation 75 2003 1291 1295
3. K.C. Abbott, C.M. Yuan, A.J. Taylor, D.F. Cruess, L.Y. Agodoa Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression J Am Soc Nephrol 14 2003 2358 2365
4. P.A. McCullough, K.R. Sandberg, S. Borzak, M.P. Hudson, M. Garg, H.J. Manley Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease Am Heart J 144 2002 226 232
5. R.S. Wright, G.S. Reeder, C.A. Herzog Acute myocardial infarction and renal dysfunction A high-risk combination Ann Intern Med 137 2002 563 570
6. M.G. Shlipak, P.A. Heidenreich, H. Noguchi, G.M. Chertow, W.S. Browner, M.B. McClellan Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients Ann Intern Med 137 2002 555 562
7. J. Ezekowitz, F.A. McAlister, K.H. Humphries APPROACH Investigators The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease J Am Coll Cardiol 44 2004 1587 1592
8. F.C. Trespalacios, A.J. Taylor, L.Y. Agodoa, K.C. Abbott Incident acute coronary syndromes in chronic dialysis patients in the United States Kidney Int 62 2002 1799 1805
9. N.S. Anavekar, J.J. McMurray, E.J. Velazquez Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295
10. F.A. Masoudi, M.E. Plomondon, D.J. Magid, A. Sales, J.S. Rumsfeld Renal insufficiency and mortality from acute coronary syndromes Am Heart J 147 2004 623 629
11. Specification Manual for National Hospital Quality Measures. Available at: http://www.jcaho.org/accredited+organizations/hospitals/oryx/aligned_manual. htm. Accessed December 15, 2005
12. M.D. Murray, L.E. Harris, J.M. Overhage Failure of computerized treatment suggestions to improve health outcomes of outpatients with uncomplicated hypertension Results of a randomized controlled trial Pharmacotherapy 24 2004 324 337
13. T.D. Sequist, T.K. Gandhi, A.S. Karson A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease J Am Med Inform Assoc 12 2005 431 437
14. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
15. National Kidney Foundation: Kidney Disease Outcomes Quality Initiative. What's New? Available at: http://www.kidney.org/professionals/doqi/kdoqi/ p4_class_g1.htm. Accessed December 15, 2005
16. M. Szelo, F.J. Nieto Epidemiology Beyond the Basics 2000 Aspen Publishers Gaithersburg, MD 435 436
17. A.C. Finley, B.M. Elliott, J.J. Robison, T.E. Brothers Prophylactic beta-blocker use to prevent perioperative morbidity and mortality J S C Med Assoc 100 2004 223 226
18. T.M. Ormiston, S.R. Salpeter Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease Moving from myth to evidence-based practice Heart Fail Monit 4 2003 45 54
19. M. Livio, A. Benigni, G. Vigano, G. Mecca, G. Remuzzi Moderate doses of aspirin and risk of bleeding in renal failure Lancet 1 1986 414 416
20. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Available at: http://www.kidney. org/professionals/kdoqi/guidelines_cvd/aspirin.htm. Accessed December 15, 2005
21. 21. Rosensen RS, Reeder GS, Kennedy HL: Beta Blockers in Acute Myocardial Infarction. Available at: www.uptodate.com. Accessed December 20, 2005